NUCLEOTIDE EXCISION REPAIR IS ELEVATED IN COMMERCIALLY AVAILABLE LATE STAGE BREAST CANCER CELL LINES AS COMPARED TO EARLY STAGE EXPLANTS, Homood As Sobeai, Jennifer Johnson, Nancy Lalanne, Omar Ibrahim
Health Professions Division REACH Day